Generics - GlaxoSmithKline

Filter

Current filters:

GlaxoSmithKline

Popular Filters

1570 to 1594 of 1643 results

GSK’s Relovair likely to emerge as market leader among once-daily LABA/ICS combinations

19-06-2011

In the asthma treatment market, at the expense of market-leading drugs that are dosed twice daily, emerging…

GlaxoSmithKlineMarkets & MarketingPharmaceuticalRelovairRespiratory and PulmonaryTheravance

AstraZeneca plans R&D center in Russia and Novartis breaks ground on new facility

17-06-2011

In yet more illustrations of multinational drug majors getting a foot hold in the fast-growing BRIC (Brazil,…

AstraZenecaEuropeFinancialGenericsNovartisPharmaceuticalResearch

Health care investments in GCC nations spur pharma growth, says IHS

16-06-2011

Demand for health care services in Gulf Cooperation Council (GCC) member states is on a strong upward…

GenericsPharmaceutical

Exports will be the key driver of growth for Czech pharma, says BMI

16-06-2011

Disputes between pharmaceutical industry associations and the Czech government have created uncertainty…

EuropeGenericsMarkets & MarketingPharmaceuticalPolitics

Adolor to pay GSK $25 million plus royalties to reacquire Entereg rights

16-06-2011

USA-based Adolor Corp (NasdaqGM: ADLR) has reached agreement with UK pharma giant GlaxoSmithKline (LSE:…

AdolorEnteregGastro-intestinalsGlaxoSmithKlineLicensingPharmaceutical

China drug formulation market could reach $150 billion by 2015

15-06-2011

It has been well recognized that the drug formulation has been one of the valued-added technologies for…

Asia-PacificGenericsMarkets & MarketingRegulation

US generics group GPhA voices worries on TPP agreement negotiations

15-06-2011

The USA’s Generic Pharmaceutical Association (GPhA) says that it has sent a letter to President…

BiotechnologyGenericsMarkets & MarketingNorth AmericaPatents

GlaxoSmithKline takes full control of Neptunus JV; links with Arecor on vaccines

15-06-2011

In one of two pieces of vaccine-related news yesterday, GlaxoSmithKline (LSE: GSK) said it is acquiring…

ArecorGlaxoSmithKlineLicensingMergers & AcquisitionsPharmaceuticalShenzhen NeptunusVaccines

Dr Reddy’s warned by US FDA over API facility in Mexico

15-06-2011

Indian generic drug major Dr Reddy’s Laboratories (NYSE:RDY) revealed yesterday that its wholly-owned…

Dr Reddy's LaboratoriesGenericsNorth AmericaRegulationSouth America

US FDA warns on risk of more serious forms of prostate cancer with 5-ARI drugs

13-06-2011

The US Food and Drug Administration has warned that the labeling for drugs used to treat enlarged prostate…

AvodartGlaxoSmithKlineMerck & CoNorth AmericaOncologyPharmaceuticalProscarRegulation

GlaxoSmithKline and Valeant get FDA approval for epilepsy drug Potiga

13-06-2011

Following backing from a US Food and Drug Administration advisory panel last summer (The Pharma Letter…

GlaxoSmithKlineNeurologicalNorth AmericaPharmaceuticalPotigaRegulationTrobaltValeant Pharmaceuticals

PATH MVI partners with GSK and Crucell to develop second-generation vaccine against malaria

08-06-2011

The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with…

CrucellGlaxoSmithKlineJohnson & JohnsonPharmaceuticalResearchTropical diseasesVaccines

Changing of the Guard begins in biotech sector

08-06-2011

The biotechnology sector is bracing for change this year as a flurry of "biosimilar" or "biogeneric"…

BiotechnologyGenericsMarkets & MarketingNorth AmericaRegulation

Pharma majors slash vaccine prices to poorest countries

07-06-2011

Several pharmaceutical majors, including the UK’s GlaxoSmithKline (LSE: GSK), US giants Merck &…

GardasilGlaxoSmithKlineGlobalJohnson & JohnsonMerck & CoPharmaceuticalPricingRotarixSanofiSanofi PasteurVaccines

EPHA calls for transparency of European medicines pricing

07-06-2011

In the framework of the European Commission consultation of the possible revision of the directive on…

EuropeGenericsPharmaceuticalPricing

UK OFT evaluation of Napp case finds increased competition in morphine market

07-06-2011

The UK’s Office of Fair Trading (OFT) has published an evaluation of its 2001 abuse of dominance…

EuropeGenericsMarkets & MarketingMorphineNapp PharmaceuticalsNeurologicalPricing

Positive Ph III results for GSK and Theravance Relovair in COPD

03-06-2011

UK pharma giant GlaxoSmithKline (LSE: GSK) and development partner Theravance (Nasdaq: THRX) of the USA…

GlaxoSmithKlinePharmaceuticalRelovairResearchRespiratory and PulmonaryTheravance

FDA denies Citizen Petition on generic Combivir 180-day exclusivity “First Applicant” issue

03-06-2011

Last week, in a seven-page response, the US Food and Drug Administration denied an October 18, 2010 Citizen…

CombivirGenericsLegalLupinNorth AmericaPatentsTeva Pharmaceutical Industries

Mylan to rebrand Matrix Labs and launch Rx products in India

31-05-2011

US generics major Mylan (Nasdaq: MYL) says that it plans to rebrand its Hyderabad, India-based subsidiary…

Asia-PacificGenericsMarkets & MarketingMatrixMylan Laboratories

1570 to 1594 of 1643 results

Back to top